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Abstract
Aims
Transcription factor GATA4 is a dosage sensitive regulator of heart development and alter-
ations in its level or activity lead to congenital heart disease (CHD). GATA4 has also been
implicated in cardiac regeneration and repair. GATA4 action involves combinatorial interac-
tion with other cofactors such as NKX2-5, another critical cardiac regulator whose mutations
also cause CHD. Despite its critical importance to the heart and its evolutionary conserva-
tion across species, the structural basis of the GATA4-NKX2-5 interaction remains incom-
pletely understood.
Methods and Results
A homology model was constructed and used to identify surface amino acids important for
the interaction of GATA4 and NKX2-5. These residues were subjected to site-directed
mutagenesis, and the mutant proteins were characterized for their ability to bind DNA and to
physically and functionally interact with NKX2-5. The studies identify 5 highly conserved
amino acids in the second zinc finger (N272, R283, Q274, K299) and its C-terminal exten-
sion (R319) that are critical for physical and functional interaction with the third alpha helix
of NKX2-5 homeodomain. Integration of the experimental data with computational modeling
suggests that the structural arrangement of the zinc finger-homeodomain resembles the
architecture of the conserved DNA binding domain of nuclear receptors.
Conclusions
The results provide novel insight into the structural basis for protein-protein interactions
between two important classes of transcription factors. The model proposed will help to
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Introduction
Transcriptional networks orchestrate complex biologic processes. Such networks are com-
monly regulated through combinatorial interactions of transcription factors. GATA family
transcriptional regulators and their co-factors control cell fate decisions in multiple tissues
from worms to mammals [1–3]. A characteristic feature of all GATA factors is a structure
with two adjacent zinc finger domains (Cys-X2-Cys-X17-Cys-X2-Cys), which mediates
binding to a DNA consensus sequence (A/T)GATA(A/G). Of the six mammalian GATA
transcription factors, GATA1, 2, and 3 are prominently expressed in hematopoietic cell line-
ages, whereas GATA4, 5, and 6 are expressed in mesoderm and endoderm derived tissues
such as heart, liver, lung, gonad, and gut [1–3]. In the developing murine heart, GATA4 is
one of the earliest-expressed transcription factors [4] and is indispensable for normal cardiac
development [5, 6]. Importantly, GATA4 is necessary and its upregulation sufficient to
induce cardiogenesis in embryonic stem cells [7] and to promote a cardiac cell fate from
non-cardiogenic cells [8–10]. GATA4 has also been implicated in cardiac regeneration and
repair [11, 12]. GATA4 is expressed also in the adult heart, acting as a key transcriptional
regulator of numerous cardiac genes including those encoding atrial natriuretic peptide
(ANP), B-type natriuretic peptide (BNP), α-myosin heavy chain (α-MHC), β-MHC, and
many others [13, 14]. In the postnatal heart, GATA4 acts as a critical regulator of hormone
response and mechanical stress as well as cardiomyocyte survival and myocardial remodeling
[15–22].
GATA4 actions involve combinatorial interactions with a number of other nuclear proteins.
Most of the interactions occur through the C-terminal zinc finger which also binds DNA and
is highly conserved throughout the GATA family. Over 20 point mutations in the C-terminal
zinc finger of GATA4 have been reported in patients with congenital heart disease. The mecha-
nisms by which mutations cause cardiac defects remain largely undefined. Recently, the struc-
ture of the C-terminal zinc finger of hGATA4 has been resolved by NMR (RCSB-Protein Data
Bank code: 2M9W) but the residues therein involved in contacting specific cofactors remain to
be identified.
The cardiac specific homeobox protein NKX2-5, a member of the evolutionary conserved NK
family of homeobox proteins and a critical GATA4 cofactor, is essential for heart development
[14, 23]. Mutations in the NKX2-5 gene are associated with congenital heart disease (CHD)
including septal defects and conduction system abnormalities [24, 25] but the mechanisms
underlying pathogenesis have not been elucidated yet. GATA4 and NKX2-5 are co-expressed in
cardiac progenitors where they are thought to be required to transduce cardiogenic, such as bone
morphogenic protein (BMP), signals [26, 27]. GATA4 and NKX2-5 interact physically and syn-
ergistically activate several cardiac genes [14, 28–31] most notably those encoding the major
secretory products of the heart: ANP and BNP. Here we combined experimental and molecular
modeling data to achieve a better understanding of the structural basis for the GATA4-NKX2-5
interaction. A homology model was constructed and used to identify surface amino acids impor-
tant for the interaction of GATA4 and NKX2-5. These residues were subjected to site-directed
mutagenesis and the mutant proteins were characterized for their ability to bind DNA and to
physically and functionally interact with NKX2-5 and with another GATA4 cofactor, Krüppel-
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like zinc finger KLF13 [32]. The results identify specific residues within the GATA4 second zinc
finger domain and C-terminal extension that are differentially required for NKX2-5 interaction.
The data shed important new insight into the structural basis for GATA4 action in the heart and
provides a platform to analyse disease-causing mutations in GATA4 and NKX2-5.
Materials and Methods
Plasmids
The plasmid expressing the mouse GATA4 (pMT2-GATA4) and the empty pMT2 plasmid
were gifts from D.B. Wilson (Department of Pediatrics, St. Louis Children's Hospital) [33] and
the plasmid expressing the mouse NKX2-5 (pEF-FLAG-NKX2-5) was provided by R.P.Harvey
(The Victor Chang Cardiac Research Institute, Darlinghurst, Australia) [34]. Mouse NKX2-5
cDNA sequence was cloned from pEF-plasmid to pMT2-plasmid to EcoRI-site using following
oligos forward: ATATATGAATTCTCCAGATCTTTCGAAATCACCATGGACTAC, reverse:
ATATATGAATTCCTTGCGTTACGCACTCACTTTAATGGGAAG. GATA4 mutations
were generated into pMT2-GATA4 plasmid which contains mouse Gata4 cDNA [33] by using
a QuikChange II Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's
protocol with the sense primers presented in Table 1. All constructs were fully sequenced to
confirm the presence of the mutations and to ensure that no additional nucleotide changes had
been introduced. The mutations are designated by their position in the mouse GATA4 protein
sequence (GenBank Accession Number NP_032118). To create p3xHA luciferase reporter
containing three NKX2-5 high affinity binding elements (NKE) (modified from the previous
studies [34, 35]) two oligos with MluI and BglII restriction sites (sense; CGCGTCTCAAGT
GGGTCTCAAGTGGAGCCTCAAGTGGA, antisense; AGAGTTCACCCAGAGTTCACCT
CGGAGTTCACCTCTAG) with phosphorylated 5’ ends obtained from Oligomer (Helsinki,
Finland) were annealed and ligated to pGL3 basic reporter vector containing rat albumin mini-
mal promoter with TATA-box (-40 - +28), a kind gift from J. Hakkola (Department of Phar-
macology and Toxicology, University of Oulu, Finland) [36]. Underlined sequences denote
NKX2-5 high affinity binding site. Rat BNP minimal promoter containing luciferase reporter
vector and minimal promoter together with -90 tandem GATA-site have been described previ-
ously [13]. Internal control vector pRL-TKd238 was a gift from J.F. Strauss III (University of
Pennsylvania School of Medicine, Philadelphia) [37]. KLF13 expression vectors and the
ANP-luciferase reporter have been previously described [32, 38].
Cell culture and preparation of the samples
COS-1 cells were a kind gift from J. Hakkola (Department of Pharmacology and Toxicology,
University of Oulu, Finland) and have originally been obtained from American Type Culture
Collection (ATCC, Manassas, VA, USA). NIH3T3 (ATCC, Manassas, VA, USA) and COS-1
cells were cultured in Dulbecco's modified Eagle’s medium (Sigma/Gibco) containing 10%
Fetal Bovine Serum (Gibco) and 1% Penicillin-Streptomycin (Sigma). For nuclear and total
protein extractions COS-1 cells were seeded into 175 cm2 culture flasks and transfected 24 h
later with 20 μg of the indicated expression vectors using FuGENE 6 (Roche) reagent. Transfec-
tion reagent was removed after 24 h and cells were collected 48 h post-transfection. Protein
extracts were prepared as previously described [39, 40].
Immunoprecipitation and immunoblotting
The relative expression levels of native and mutant GATA4 proteins were evaluated by western
blot and used to adjust the required volume of cell extract from transfected cells in order to
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standardize the amount of GATA4 protein in each immunoprecipitation. The total protein
concentration was kept equal between the samples by the addition of protein extract from
untransfected cells as required. For each immunoprecipitation, 50 μg of protein from
FLAG-NKX2-5 expressing cells, 30–84 μg of protein from GATA4 expressing cells and
0–54 μg of protein from non-transfected cells were used. Thirty microliters of agarose bound
anti-FLAGM2 antibody (Sigma) was used per immunoprecipitation reaction followed by over-
night incubation in lysis buffer (20 mM Tris, pH 7.5, 150 mMNaCl, 1 mM EDTA, 1 mM
EGTA, 1% Triton X-100 and 2.5 mM sodium pyrophosphate) with protease and phosphatase
inhibitors (20 μg/ml leupeptin, 2 μg/ml pepstatin, 20 μg/ml aprotinin, 1 mM phenylmethane-
sulfonyl fluoride (PMSF), 50 mM NaF, 6 μg/ml N-tosyl-L-phenylalaninyl-chloromethylketone
(TPCK) and 6 μg/ml N-alpha-tosyl-L-lysinyl-chloromethylketone (TLCK)) at +4°C with gentle
agitation. The beads were collected by quick spin and washed three times with lysis buffer. The
immunoprecipitated proteins were eluted from the agarose beads by boiling the samples in
SDS-loading buffer, resolved by SDS-PAGE as divided into duplicate, transferred onto Opti-
tran BA-S 85 Reinforced nitrocellulose membrane (Schleicher & Schuell) and immunoblotted
with anti-GATA4 polyclonal antibody (sc-9053, Santa Cruz Biotechnology) and anti-NKX2-5
polyclonal antibody (sc-8697, Santa Cruz Biotechnology). Horseradish peroxidase-conjugated
anti-rabbit IgG or anti-goat IgG was used as secondary antibody. The immune complex was
visualized by using an ECL detection kit (Amersham Pharmacia Biotech) followed by exposure
to film (Hyperfilm ECL, Amersham Biosciences) or digitalization of chemiluminescence with
Luminescent Image Analyzer LAS-3000 (Fujifilm). All immunoreactive bands were quantified
using Quantity One software (Bio-Rad).
For the analysis of the results, the input GATA4 bands were normalized to input wtGATA4,
i.e. control bands. Similarly, the NKX2-5 bands were normalized to control NKX2-5. First, the
average intensity of the unspecific binding was subtracted from the intensity of the
Table 1. Primers used to create the GATA4mutations.
Amino acid mutated Primer 5' to 3' direction
V217Y CAGAAGGCAGAGAGTGTTACAATTGTGGGGCCATGTC
H234S GAGATGGGACGGGAAGCTACCTGTGCAATGCC
R264A CTGTCCGCTTCCGCCCGGGTAGGCCTC
S269C GGGTAGGCCTCTGCTGTGCCAACTGCCAG
A271V GCCTCTCCTGTGTCAACTGCCAGACTACC
N272S CCTCTCCTGTGCCAGTTGCCAGACTACCACC
N272D GTAGGCCTCTCCTGTGCCGATTGCCAGACTACCAC
Q274H CCAACTGCCATACTACCACCACCACGCTG
R283A GCTGTGGCGTGCTAATGCCGAGGGTGAGC
R283Q CGCTGTGGCGTCAAAATGCCGAGGGTGAGC
E288G GCCGAGGGTGGGCCTGTATGTAATGCCTG
E288K GCGTCGTAATGCCGAGGGTAAGCCTGTATG
M298Y CGGCCTCTACTACAAGCTCCATGGGGTTCCCAGG
K299A CGGCCTCTACATGGCGCTCCATGGGGTTC
R319C CCAGAAAATGTAAGCCCAAGAACCTGAATAAATCTAAGACGCC
R319S CGGAAGGAGGGGATTCAAACCAGAAAAAGCAAGCCCAAGAAC
P321C GGAGGGGATTCAAACCAGAAAACGGAAGTGCAAGAACC
S327A GCCCAAGAACCTGAATAAAGCTAAGACGC
Highlighted nucleotides denote mutated codons.
doi:10.1371/journal.pone.0144145.t001
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immunoprecipitated sample, which was then adjusted to input GATA4 level and normalized
to control. These normalized values were finally adjusted to normalized NKX2-5 values. Each
value from biological and technical replicates was treated separately and combined for statisti-
cal calculations.
Electrophoretic mobility shift assay (EMSA)
Double-stranded oligonucleotides corresponding to the -90 GATA binding region of the BNP
gene were used for the analysis of GATA4 DNA binding activity as previously described [39].
Probes used: rBNP -90 tandem GATA (sense 5'-TGTGTCTGATAAATCAGAGATAACCCC
ACC-3'; antisense 5'- GGTGGGGTTATCTCTGATTTATCAGA-3'), rBNP GATAmut -91
(sense 5'- TGTGTCTTGCAAATCAGAGATAACCCCACC-3'; antisense 5'-GGTGGGGTT
ATCTCTGATTTGCAAGA-3'), rBNP GATAmut -80 (sense 5'-TGTGTCTGATAAAT
CAGATGCAACCCCACC-3'; antisense 5'-GGTGGGGTTGCATCTGATTTATCAGA-3') and
rBNP -91GATA (sense 5'-TGTGTCTGATAAATCAGAG-3'; antisense 5'-CTCTGATTTAT
CAGA-3'). GATA binding sites are indicated in bold and the mutated nucleotides are under-
lined. Anti-GATA4 polyclonal antibody (sc-1237X, Santa Cruz Biotechnology) was used for
super shift assays. The bands were quantified using Quantity One software (Bio-Rad). For the
analysis of the results each band was normalized to the average of the control bands. The nor-
malized values were combined for statistical calculations.
Luciferase reporter assay
In luciferase reporter assays COS-1 or NIH3T3 cells were co-transfected with 150 ng of Firefly
luciferase reporter vector, 35 ng Renilla luciferase vector and 75 ng of expression plasmid
pMT2-GATA4 per 1 cm2 well. In GATA4-NKX2-5 interaction studies with p3xHA the same
amount of luciferase reporter vectors were used along with 75 ng of pMT2-NKX2-5 and 75 ng
of pMT2-GATA4 plasmids. Particular GATA4 mutant proteins required adjustment in the
transfected plasmid amount to achieve equal protein levels. Twenty-four hours after transfec-
tions cells were lysed with 1x Passive Lysis Buffer (E194A, Promega). The samples were pro-
cessed with Dual-Luciferase Assay system according to manufacturer’s protocol (E1960,
Promega) and measured with a luminometer (Luminoskan RS, Labsystems, Helsinki, Finland).
NIH 3T3 cells were used to study the transcriptional activity of GATA4 mutants on the ANP
promoter. Several doses of pMT2-GATA4 with or without varying doses of the other expres-
sion vectors were used to assess changes in transcriptional activities of GATA4 mutants over a
wide range of DNA concentrations, which more accurately reflects transcriptional changes rel-
ative to the wt protein. Similarly, synergy with NKX2-5 was tested at different concentrations
of GATA4 expression vectors to ensure the validity of the conclusions and to avoid artifacts
due to the use of DNA concentrations outside the linear range. For the analysis of the results,
the Firefly values were divided with the Renilla values and then normalized into control values.
Each value from biological and technical replicates was treated separately and combined for
statistical calculations.
Molecular modeling
A homology model of GATA4 was constructed using the highly conserved zinc finger domains
of GATA1 and GATA3 as template structures (PDB codes 1GNF for the N-terminal zinc finger
and 3DFX for the C-terminal zinc finger of GATA4, sequence identities 84% and 76%, respec-
tively). The model of the homeodomain of NKX2-5 was built by using the homeodomain of
the related thyroid transcription factor 1 as a template (sequence identity 61%). Models built
for the zinc fingers of GATA4 cover amino acids from 204 to 324 and for the homeodomain of
Structural Basis for GATA4 and NKX2-5 Interaction
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NKX2-5 amino acids 146–198. The sequence alignments were constructed using PSI-BLAST
and did not contain any insertions or deletions. The MOE software (Chemical Computing
Group Inc, Canada) was used to construct the homology models of the protein domains.
AMBER99 force field was applied as a source of atom parameters for all minimizations and
scoring. Side chain data was assembled from an extensive rotamer library. Totally, 11 protein
models were generated by the Boltzmann-weighted randomized modeling procedure (10 inter-
mediate models and a refined final model). Each model was submitted to an electrostatics-
enabled minimization run until Root Mean Square (RMS) gradient falls below 1. Protein mod-
els were scored by using the Generalized Born/Volume integral (GB/VI) methodology [41].
The best scoring intermediate model was further minimized until RMS falls below 0.5 and
selected as a final model. Subsequently, the best scoring models were inspected and confirmed
to have satisfactory stereochemical quality with Ramachandran plots [42].
Statistical analysis
All the results are expressed as mean±SEM. To determine the statistical difference between two
groups, Student’s t-test was used. In luciferase assays one group was considered as a control
and all other groups were compared against it with Dunnett’s t-test using IBM SPSS Statistics
software (Version 21.0. Armonk, NY: IBM Corp.). Differences at or above the 95% confidence
level were considered statistically significant.
Results
Mapping of the key amino acids for GATA4-NKX2-5 physical interaction
The homology model of GATA4 was developed to design point mutations for identifying cru-
cial amino acids for GATA4-NKX2-5 interaction (Fig 1A–1C). Preferably, the amino acids
were selected to evenly cover the surface of the C-terminal zinc finger of GATA4 excluding the
amino acids needed for DNA binding. Previous studies indicated that the second zinc finger
and a C-terminal extension were required to contact NKX2-5 [14]. We therefore focused on
these regions. Thirteen C-terminal zinc finger point mutations (R264A, S269C, A271V,
N272D, N272S, Q274H, S269C+Q274H, R283A, R283Q, E288G, E288K, M298Y, K299A) and
four C-terminal extension mutations (R319C, R319S, P321C, S327A) of GATA4 protein were
generated. In addition, two mutations were produced in the N-terminal zinc finger (V217Y,
H234S). The positions of all mutated residues are depicted in Fig 1C. Since all mutations were
located outside the antibody recognition site, western blots were used to quantify the mutant
protein levels produced in mammalian COS-1 cells. All mutant proteins are expected to localise
to the nucleus like native GATA4 since single amino acid substitution in zinc finger area is not
sufficient to inhibit the nuclear trafficking [43, 44]. Physical interactions with NKX2-5 were
assessed in co-immunoprecipitation with N-terminal FLAG-NKX2-5 and analysed by western
blots using GATA4 and NKX2-5 antibodies (Fig 2). The input samples confirmed the amount
of GATA4 proteins used in the assays. Each mutation was studied in duplicate experiments
with two technical replicates. Quantifications were performed on two reproducible blots and
are presented in Fig 3 (raw data available in S1 File).
First, we analysed the effects of mutations in the GATA4 C-terminal zinc finger. Single amino
acid mutations of E288K or E288G had no effect on interaction while R283A significantly
decreased binding of GATA4 with NKX2-5 (84%, p<0.001). Substitution of arginine with the
similarly sized but uncharged amino acid glutamine (R283Q) also significantly inhibited
GATA4-NKX2-5 binding (91%, p<0.001) (Fig 3). Based on the homology model of GATA4, we
created mutations R264A and K299A, which locate adjacent to and on the same surface but
opposite direction to R283 (Fig 1B). Both mutations significantly decreased GATA4 binding to
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NKX2-5 (R264A, 36% p<0.05; K299A, 61%, p<0.01) (Fig 3). These results indicate that the
three basic residues R264, R283 and K299 are important in contacting NKX2-5.
Next, we analysed the contribution of the amino acid M298, which is located in the helix.
The side chain orientation of M298 is opposite to K299 (Fig 1B) and may provide a protein-
protein interface. Mutation of this residue to tyrosine (M298Y), the amino acid found at this
position in the hematopoietic GATA1-3 subclass, decreased GATA4 binding to NKX2-5 by
62% (p<0.001) (Fig 3). Mutation of N272 locating near M298 in the folded GATA4 protein
(Fig 1B) is also found in humans (N273S) and causes heart malfunctions [45]. Interestingly,
N272D also reduced GATA4-NKX2-5 binding albeit to a lesser extent (Fig 3). On the other
hand, when the amino acid next to N272 in the loop area was mutated (A271V), no significant
effect on the interaction between the two proteins was noted (Fig 3). By contrast, mutation of
Q274 to histidine, the corresponding amino acid in GATA5 and GATA6 [1] decreased the
interaction by 47% (p<0.05). Mutation of another residue, S269 to the corresponding
GATA5 amino acid (S269C) had no significant effect (Fig 3). The double mutant protein
(S269C+Q274H) which mimics GATA5 was as effective as wild type (wt) GATA4 in NKX2-5
interaction consistent with the ability of both wild type and mutant proteins to similarly syner-
gize with NKX2-5.
In addition to the second zinc finger, GATA4 C-terminal extension (AA 303–390) is impor-
tant for binding NKX2-5 [14]. C-terminal extension mutations R319C, R319S or P321C were
created to mimic the amino acid combination observed in the protein model for NKX2-5 inter-
face (Fig 1C). Here we intended to design an internal competing motif that could block NKX2-
5 binding. Additionally, R319S was tailored to avoid possible formation of sulphur bridges in
the experiment. A putative phosphorylation site S327 was also mutated (S327A), but this had
Fig 1. Homology models of transcription factor GATA4 bound to DNA. (A) Double GATA4 bound to a tandemGATA binding site. (B) C-terminal zinc
finger of GATA4 bound to the major groove of DNA along with the N-terminal zinc finger bound to the minor groove. Amino acids N272 and R283 are
highlighted as ball spheres and the location of amino acids H234, R264, M298, K299 and R319 are indicated. (C) Amino acid sequence of the mouse GATA4
zinc fingers. Darker shades indicate residues mutated in this study.
doi:10.1371/journal.pone.0144145.g001
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no effect on NKX2-5 binding. R319C strongly decreased the GATA4-NKX2-5 interaction
(89%, p<0.001) (Fig 3). On the other hand, R319S and P321C had no significant effects.
Finally, as control, we produced two mutations in the N-terminal zinc finger. Amino acid
V217 has been shown to be important for GATA4-FOG2 interaction [46]. Interestingly,
V217Y mutation strongly increased (235%, p<0.05) GATA4-NKX2-5 binding (Fig 3), while
mutation of H234S, located next to V217, had no effect (Fig 3). We conclude that of the amino
acids tested, the significant structural determinants for GATA4 interaction with NKX2-5 are
R264, N272, Q274, R283, M298, K299 and R319.
Role of specific amino acids in GATA4 DNA binding
The amino acids studied above are on the surface of the native folded GATA4 protein and are
not expected to alter the GATA4 zinc finger structure. The effects of the particular mutations
on GATA4 DNA binding properties were studied by EMSA using the tandem GATA binding
region of the BNP promoter as a probe (Fig 4A). GATA4 binding to this region creates two
bands on EMSA as confirmed in supershift experiments with the anti-GATA4 antibody (Fig
4B). Each mutation was analysed in from two to nine independent experiments. As expected,
most of the mutations did not influence on DNA binding (Fig 4C–4F). The greatest effect was
caused by the R283A mutation, which decreased DNA binding by 72% (p<0.001) (Fig 4C and
4F). Of note, mutations R264A and K299A showed consistently distinct binding patterns in
EMSA (Fig 4D): R264A enhanced binding in the upper band and K299A in the lower band.
However, when the intensities of both bands were added there was no significant effect in total
DNA binding (Fig 4F). To explore if the two GATA elements were needed for GATA4 binding,
DNA binding was tested with probes containing only one GATA site (Fig 4A and 4E). Muta-
tion of the distal GATA site (GATA mut -91) reduced formation of the upper band, whereas
mutation of the proximal GATA site (GATA mut -80) eliminated it; deletion of the entire
proximal GATA site (-91 GATA), resulted in the formation of only one (the lower) band.
These results suggest that the upper band represents binding of two GATA4 molecules to the
Fig 2. Representative Western blots following co-immunoprecipitation of GATA4mutant proteins and NKX2-5-FLAG produced in COS-1 cells. For
each GATA4 mutation immunoprecipitation was carried-out in two independent experiments with two technical replicates on western blot. The level of
GATA4 protein in the input is shown below each co-ip blot. IP, immunoprecipitation; IB, immunoblotting
doi:10.1371/journal.pone.0144145.g002
Fig 3. Effect of GATA4mutations on interactions with NKX2-5.Quantitative analysis of GATA4 proteins binding to wtNKX2-5-FLAG. The effect of
GATA4 mutations on GATA4-NKX2-5 interaction (black bar) is expressed as fold-changes compared to wtGATA4 control group (white bar). The raw data of
the quantifications is available in S1 File. The results are presented as mean of two independent experiments ±SEM. * P<0.05, ** P<0.01 and *** P<0.001
vs. control group (Student's t-test).
doi:10.1371/journal.pone.0144145.g003
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Fig 4. GATA4 binding to the tandemGATA site of the BNP promoter. (A) Schematic representation of the probes used in EMSA studies. (B) GATA4
binding to rBNP -90 tandemGATA site created two different bands. Supershift (SS) with 4 μg of GATA4 antibody C-20 confirms GATA4 presence in both
bands. (C) The rBNP -90 tandemGATA site was used to study the effect of mutations on DNA binding. (D) R264A and K299Amutant proteins caused
distinct binding pattern. (E) WtGATA4 binding to tandemGATA sites was studied with different mutated probes. 2xG = binding of two GATA4 molecules,
Structural Basis for GATA4 and NKX2-5 Interaction
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tandem GATA elements as previously observed for GATA-1; [47] they also show that muta-
tions in certain residues within the second zinc finger are needed for cooperative binding of
GATA4 to DNA elements containing tandem GATA sites.
The model for GATA4 bound to DNA suggests that amino acids R264, R283 and K299 are
located on the same side of the C-terminal zinc finger and are responsible for proper internal
packing of the two zinc fingers. Upon DNA binding, the C-terminal zinc finger of GATA4
binds the major groove and the N-terminal zinc finger occupies the minor groove allowing
interaction with the second GATA4 bound to the tandem GATA binding sites, located at a dis-
tance of 11 base pairs (Fig 1A). When either of the GATA elements was mutated, the binding
of two GATA4 molecules was diminished. Interestingly, mutations of all these amino acids
reduced the interaction with NKX2-5. In addition, K299A and R283A were associated with a
unique gel shift pattern with the decreased ability to form dimers (Fig 4C and 4D). Together,
these observations indicate that distinct intra- and intermolecular interactions are required to
control GATA4 binding to various DNA regulatory elements.
Functional effects of the GATA4 mutants
The effect of GATA4 mutations on transcriptional activity was studied using luciferase reporter
assays (raw data available in S2 File). The minimal BNP promoter containing the first 60 bp
including the proximal TATA-box (Fig 5A) as well as a reporter containing the minimal pro-
moter and the -90 tandem GATA-sites (2XGATA, Fig 5B) were used. The expression level of
the proteins was quantified by western blots and as shown in Fig 5C was similar for all GATA4
mutant proteins. Overall, when compared to the 3-fold activation by wtGATA4, all mutations
tested, except the ones in the N-terminal zinc finger, showed decreased activation of the mini-
mal promoter (p<0.001). The BNP promoter containing the -90 tandem GATA sites was acti-
vated 8-fold by wtGATA4 (Fig 5B). Only some of the GATA4 mutations affected
transcriptional activity on this promoter. The strongest decrease in reporter activation was
seen with mutants N272D, N272S, R283A, R283Q and K299A (67–76%, p<0.01).
GATA4 shows enhanced synergistic effect with NKX2-5 on promoters containing high
affinity binding elements for NKX2-5 (NKE) [31, 48]. To evaluate the impact of mutations on
functional interaction with NKX2-5, we first studied GATA4-NKX2-5 transcriptional synergy
on an artificial construct containing 3xNKE. As shown in Fig 5D, wtGATA4 alone had no
effect, while NKX2-5 activated the 3xNKE promoter alone and synergistically with GATA4.
Strikingly, the strongest inhibitory effect on synergy was noted with GATA4 proteins contain-
ing N272 mutations (N272D 79% and N272S 65% reduction vs wtGATA4, p<0.001). Signifi-
cant reduction (p<0.05) was also seen with mutations E288G, R283A, R283Q, K299A, R319C,
R319S, P321C, and S327A. Finally, V217Y, which increased physical interaction with GATA4,
also increased synergy with NKX2-5 in the luciferase reporter assays (146%, p<0.001) (Fig
5D).
Effect of GATA4 mutations on the transcription of ANP promoter
The effect of representative GATA4 mutations on the transcriptional activity of the ANP pro-
moter was also studied using luciferase reporter assays. This promoter contains two high affin-
ity GATA binding sites adjacent to NKE sites [14, 49, 50]. First, a dose response study was
conducted to determine the profile of the GATA4 mutants on a natural GATA4 target
1xG = binding of one GATA4 molecule. Arrowheads denote free probes. (F) Effect of the GATA4mutations (black bar) on DNA binding activity is expressed
as fold-changes compared to wtGATA4 control group (white bar). Results (mean±SEM) are averages from two to nine independent reproducible EMSA
samples using the -90 tandemGATA probe (n = 1–3). * P<0.05, ** P<0.01 and *** P<0.001 vs. control group (Student's t-test).
doi:10.1371/journal.pone.0144145.g004
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promoter (data not shown). Several GATA4 mutations affected transcriptional activity: a sig-
nificant decrease in GATA4 activation of the ANP reporter was observed with the point
mutant K299A (52% p<0.01) and a complete loss of GATA4 transcriptional activation was
observed with N272S, R283A, and R319C (p<0.01) (Fig 6A). This profile is quite similar to the
one obtained with the longer BNP promoter (Fig 5B). Mutations R264A, E288G and S327A
had a stronger effect on ANP promoter activation compared to that of BNP, likely reflecting
the more complex protein-protein interactions on this promoter.
The same mutants were examined for their effect on cooperative activation of the ANP pro-
moter with NKX2-5 (Fig 6B). Mutants N272S and E288G reduced the synergistic interaction
Fig 5. Effect of GATA4mutations on transcriptional activity in COS-1 cells. (A) Results using the rat BNPminimal promoter and (B) the rat BNP
promoter with the -90 tandemGATA sites (2XGATA). Results (mean±SEM) are expressed as fold-changes compared to pMT2 control group and are
averages from three independent experiments with parallel samples (n = 3). (C) The mutant GATA4 proteins were expressed at the same level as the
wtGATA4 protein. A representative western blot shows that 1.5-fold higher amount of the M298Y, R319C and R319S plasmids, and 2.5-fold higher of the
K299A plasmid compared to the wtGATA4 were transfected to achieve equal protein levels. (D) A reporter construct containing three high affinity binding
sites for NKX2-5 (NKE) was created to study transcriptional interaction between GATA4 and NKX2-5 proteins. The experiment was repeated two times with
parallel samples (n = 2). The raw data of the luciferase assay is available in S2 File. Results (mean±SEM) are expressed as fold-changes compared to
wtGATA4-NKX2-5 control group. * P<0.05, ** P<0.01 and *** P<0.001, vs. wtGATA4 in A and B and vs. wtGATA4-NKX2-5 in D (Dunnett’s t-test).
doi:10.1371/journal.pone.0144145.g005
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with NKX2-5 most significantly (p<0.05). As with the 3xNKE reporter, K299A and R319C
also decreased synergy.
Fig 6. Effect of GATA4mutations on ANP promoter activation in NIH3T3 cells. The -699bp ANP
promoter was utilized to study the transcriptional activity of the GATA4 mutants on a validated GATA4 target
gene. (A) Promoter activation by the indicated GATA4 proteins; activation by wtGATA4 is set at 1. (B) Effect
of mutated GATA4 on synergy with NKX2-5 and (C) on synergy with KLF13. The data shown are from two
independent experiments conducted in duplicate using five different DNA concentrations. Results (mean
±SEM) are expressed as fold-changes compared to the control groups wtGATA4 in (A), wtGATA4-NKX2-5 in
(B), and wtGATA4-KLF13 in (C). * P<0.05, ** P<0.01 and *** P<0.001 vs. control group with Student's t-
test.
doi:10.1371/journal.pone.0144145.g006
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Effect of GATA4 mutations on interaction with other cofactors
To further define the specific amino acids for GATA4-NKX2-5 interaction we also examined
the effect of GATA4 point mutations on the synergy with another GATA4 cofactor, KLF13
transcription factor. In contrast to NKX2-5, KLF13 contacts GATA4 via its N-terminal zinc
finger [32]. As shown in Fig 6C, most GATA4 mutants did not affect synergy with KLF13 on
ANP promoter. In fact, only two mutations significantly reduced synergy with KLF13, one in
the second zinc finger (R283A) and the other in the basic domain (R319C). Interestingly, these
mutations inhibited more effectively KLF13 synergy than NKX2-5 synergy.
Proposed Model for GATA4-NKX2-5 interaction
Nuclear receptors have two zinc fingers packed together with conserved amino acid residues
mediating the interaction between the first and second zinc finger (Fig 7A). The C-terminal
zinc finger of GATA4 shares the structural fold of other C4-type zinc fingers including the first
zinc finger of nuclear receptors. On the other hand, helix III of the second zinc finger of these
receptors contains a conserved helical structure mediating interaction between the two zinc fin-
gers, such as estrogen receptor residues R63, K66 and C67 [51]. Detailed structural analysis
Fig 7. Nuclear receptor like structure of GATA4-NKX2-5 interaction. (A) DNA-binding domain of the
estrogen receptor (Protein Data Bank: 1HCQ) showing R63, K66 and C67 mediating the interaction between
the zinc fingers. (B) Homology model of the C-terminal zinc finger of GATA4 (green) and the homeodomain of
NKX2-5 (blue) showing amino acids R190, K193 and C194 (S3 File). Structure similarity between GATA
model and Estrogen receptor (1HCQ) is 1.81 RMSD (alpha-carbon). Due the sequence and structural fold
differences between NKX2-5 and Estrogen receptor, RMSD values are not reported. Zinc atoms are
represented as light blue spheres.
doi:10.1371/journal.pone.0144145.g007
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revealed that helix III in the homeodomain of NKX2-5 has a nuclear receptor-like binding
motif as well. Sterically accessible NKX2-5 amino acids R190, K193 and C194 are arranged
similarly in a helical motif as the corresponding residues in the estrogen receptor (Fig 7B). Pre-
viously it has been shown that helix III of NKX2-5, especially K193, is required for association
with the C-terminal zinc finger of GATA4 [52]. Remarkably, our model predicts that the inter-
action between GATA4 and NKX2-5 shares the same architecture seen for the two zinc fingers
in the DNA binding domain of nuclear receptors (Fig 7B, S3 File).
Discussion
GATA4 is a dosage-sensitive regulator of heart development and changes in GATA4 protein
levels or activity may lead to congenital heart disease [53, 54]. Over 90 point mutations in
GATA4 have been associated with human congenital heart disease with the majority found in
the two zinc fingers and C-terminal domains. In most cases, the mechanisms of pathogenesis
remain largely unidentified but it is assumed that mutations lead to haploinsufficiency. Indeed,
in the few cases where the effect of the mutations have been tested, a decrease in GATA4 activ-
ity was noted [55–59]. However, several mutations did not have an effect on GATA4 transcrip-
tional activity while others appear to be gain-of-function mutations [60]. The molecular basis
underlying the changes in GATA4 activity caused by these single point mutations remains to
be defined. Alterations in nuclear accumulation, DNA binding, or protein-protein interactions
can have profound effects on GATA4 activity. In particular, differential effects on GATA4
interaction with its cofactors may help elaborate genotype-phenotype relations. So far, only a
handful of GATA4 mutations have been shown to affect cofactor interactions. They include
mutation in the N-terminal domain that alter Cyclin D2 interaction and that was identified in
familial atrial fibrillation; [59] mutation in the first zinc finger that prevents FOG2 association
and was found in testicular defects; [61] two mutations, one in the second zinc finger and the
other in the adjacent nuclear localisation domain that prevent physical interaction with TBX5,
found in familial tetralogy of fallot and in septal defects; [55, 58] and last, C271S in the N-ter-
minal end of the second zinc finger that reduces synergy with NKX2-5 and was found in an
autosomal dominant form of dilated cardiomyopathy [57]. A better understanding of the struc-
ture-function determinants of GATA4 is a prerequisite for elucidating the mechanisms by
which mutations in GATA4 lead to defective heart formation and for developing genotype-
phenotype relations.
As stated earlier, the role of GATA4 in the heart ranges from differentiation, survival and
proliferation of cardiac progenitors to adaptive stress response, angiogenesis and myocardial
repair of the post-natal heart. The diverse GATA4 functions are thought to involve differential
interactions with cell-specific and signal-inducible cofactors. For example, interaction with the
calcium-calcineurin inducible transcription factor NFAT may underlie the hypertrophic
response [62] whereas cooperativity with growth factor responsive proteins such as Smad,
STAT (signal transducers and activators of transcription) and Jun/Fos may be required for pro-
liferative growth and for hormonal response [63, 64]. On the other hand, GATA4 is known to
activate cardiac gene transcription synergistically with several classes of cardiac-specific tran-
scription factors and while the exact role of these interactions is not fully elucidated, their evo-
lutionary conservation, together with genetic and biochemical evidence point to important
functions in heart development.
In this study, we conducted a mutagenic analysis of the second zinc finger domain aimed at
elucidating the structural basis for GATA4-NKX2-5 interaction. The results summarized in
Table 2 identify specific residues within this domain and its C-terminal extension that are
involved in physical and functional interaction with NKX2-5. Integration of the experimental
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data with computational modelling suggests that the topology of the GATA4-NKX2-5 interac-
tion is reminiscent of that observed between the two zinc fingers of nuclear receptors. The
unexpected finding that GATA4-NKX2-5 interaction resembles that of nuclear receptors may
have far-reaching implications for understanding the molecular consequences of pathogenic
GATA4 and NKX2-5 mutations. Given the wealth of information on nuclear receptor struc-
ture, regulation and cofactors, the structural similarity unravelled from this work may assist
studies aimed at clarifying the regulation and molecular components of GATA4-NKX2-5 tran-
scription complexes.
Earlier work has shown that the second zinc finger of GATA4 contacts NKX2-5 homeodo-
main and suggested that this interaction induces a conformational change that unmasks
NKX2-5 activation domains [14]. This protein-protein interaction requires an intact zinc fin-
ger structure but was not strictly dependent on GATA4 binding since NKEs were sufficient to
mediate synergy [48]. For NKX2-5, the C-terminus of the homeodomain which harbours the
α3 helix and a short C-terminal extension of the homeodomain were needed to contact
GATA4 [14, 50]. Based on our mutational studies and molecular modeling of interactions
between GATA4 and NKX2-5, the GATA4 mutations created can be classified into different
hot spots. In general, hot spots are a small subset of contact residues contributing significantly
to the binding free energy and therefore are drivers for the protein-protein interactions [65].
Even the one amino acid mutation at the hot spot region has an influence to the interaction,
and in addition to this, specific amino acid change play a substantial role leading to different
surface properties (charge, size, hydrophobicity). First, mutations of the GATA4 residues
R264, R283 and K299 resulted in loss of protein-protein interaction. Moreover, DNA binding
Table 2. Summary of GATA4 structure function.
GATA4
mutation
DNA
binding
Promoter
activation
NKX2-5
binding
Synergy with NKX2-5 on
3xNKE
Synergy with NKX2-5
on ANP
Synergy with KLF13
on ANP
WT Normal Normal Normal Normal Normal Normal
V217Y Normal Normal " " Normal "
H234S Normal Normal Normal Normal # Normal
R264A Altered Normal # Normal Normal Normal
S269C # Normal Normal Normal ND ND
A271V # Normal Normal Normal ND ND
N272D # # # # ND ND
N272S # # Normal # # Normal
Q274H Normal Normal # Normal # Normal
S269C+Q274H # Normal Normal Normal ND ND
R283A # # # # Normal #
R283Q Normal # # # ND ND
E288G Normal Normal Normal # # Normal
E288K Normal Normal Normal Normal ND ND
M298Y Normal Normal # Normal Normal Normal
K299A Altered # # # # Normal
R319C # # # # # #
R319S Normal Normal # # ND ND
P321C Normal Normal Normal # ND ND
S327A Normal Normal Normal # Normal Normal
" = increased vs. wt, # = decreased vs. wt, ND = not determined
doi:10.1371/journal.pone.0144145.t002
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experiments showed that these mutations create a distinct binding pattern and in particular
affect cooperative binding over tandem GATA elements. The molecular model for the interac-
tion between GATA4 and DNA suggests that C- and N-terminal domains are packed together
and their orientation towards each other either activates or restricts binding of a second
GATA4 protein to the promoter (Fig 1A). A similar intramolecular binding mode on palin-
dromic GATA sites has been observed with GATA1 [47]. We assume that if R264 is mutated,
N- and C-terminal zinc fingers are packed together and allow two GATA4 proteins to better
bind this sequence. In contrast, K299A, adopting a more open conformation, allows only one
GATA4 protein to be bound. The results of transcriptional assays are in agreement with this
hypothesis. R264A is able to activate the promoter containing a tandem GATA-site similarly to
wtGATA4, in contrast to K299A, which was unable to bind this sequence properly and to acti-
vate transcription. These results and their interpretation are consistent with the work of Philips
et al. [43], who showed that mutation of R283 and K299 reduces DNA binding to a monomeric
GATA element. Alterations in the packing of C- and N-terminal zinc fingers may thus be the
cause for the strongly reduced GATA4-NKX2-5 physical interaction detected with these
mutants.
Furthermore our studies demonstrate that N272 is a crucial amino acid for GATA4-NKX2-
5 interaction, as shown by the strong inhibition of transcriptional synergy with NKX2-5 but
not with KLF13. N272 is situated in close contact (approx. 5 Å) to M298. Since both mutations
decreased the protein-protein interaction at least moderately and are located on the opposite
side of the DNA binding surface of GATA4 (Fig 1B), we assume that this could be the potential
binding site for NKX2-5. The effect of the N272 mutation was not clear-cut in immunoprecipi-
tation assays. On the other hand, the relevance of this residue was more pronounced in our
reporter assays, in which N272D and N272S were clearly unable to activate any of the promot-
ers tested. This might be a consequence of small spatial or structural change in the physical
assembly of the interacting proteins as a protein complex leading to unpredictable and strong
effects in function. N272 is located specifically at the site that is analogous to the binding sur-
face needed for internal packing of zinc fingers in nuclear receptors; M298 and N272 form a
site on the protein surface that could harbor the cysteine containing sequence of α-helix III in
NKX2-5.
Lastly, from the nuclear receptor analogy, we deduced that the binding interface should con-
tain at least a successive cysteine and lysine in a helix structure to enable binding. Mutations
R319C and R319S were designed to inhibit the protein-protein interaction by creating an inter-
nal protein motif, which might compete with NKX2-5 by occupying its binding site. Indeed,
mutations at R319 (to cysteine or serine) showed decreased synergistic activity with NKX2-5
that was most severe on the NKE-dependent promoter. The finding that residues in the
GATA4 basic domain are involved in modulating NKX2-5 interaction is consistent with our
initial report on GATA4-NKX2-5 cooperativity [14]. In summary, we find that GATA4 amino
acids N272, R283, K299, R319 are essential for interaction with NKX2-5 consistent with the
structural model presented. These results may help explain the basis for several GATA4 muta-
tions associated with congenital heart disease, including N273S, R283H, N285L and K319E
[45, 66].
From the NKX2-5 perspective, half of the reported 40 heterozygous human mutations
reside in the homeodomain [24]. The mechanisms by which these mutations cause disease,
most notably atrial septal defects and AV block, remain to be elucidated. The model proposed
here predicts that NKX2-5 amino acids R190, K193 and C194 would be involved in contacting
GATA4. Consistent with this, analysis of the R190H and neighboring G187H human muta-
tions showed that these changes abrogate physical interaction between NKX2-5 and GATA4
but do not affect NKX2-5-TBX5 interaction while Y191C and N188K did not disrupt the
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interaction between GATA4 and NKX2-5 [67]. These data further support our proposed
model which may provide a helpful basis for understanding disease-causing mutations in these
two critical cardiac regulators.
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